Startup Companies

InnoBioPharma has developed several novel drug candidates (two in pre-clinical trials) that are particularly effective against aggressive cancers that lack effective drug therapy.

A therapeutic vaccine for patients with recurrent prostate cancer that effectively destroys expressing tumor cells while leaving normal cells unharmed.

University of Nebraska-Lincoln researchers are developing a novel protein based delivery technology that targets sensory neurons to stop pain signals at the source to avoid systemic toxicity and addiction potential.

The United States has about 220,000 cases a year of acute respiratory distress syndrome, or ARDS, which deactivates the naturally occurring lung surfactant in patients. That causes a decreased ability to inflate the tiny air sacs in lungs called alveoli. When inadequately inflated, the alveoli cannot totally oxygenate a patient’s blood stream, which can lead to organ failure and other health problems.

Viosera targets under-served deadly infectious disease markets. We use existing FDA-approved and off-patent drugs and combine them in ways that enhance their effectiveness against the deadliest infections.

Accuronix Therapeutics is a leader in discovering and developing a new class of drugs that work by selectively targeting the σ-2 (sigma-2) receptor on cancer cells to deliver cytotoxic payloads.

Each year, in the United State alone, 160,000 people develop heart failure from acute heart damage. This results in more than $17 billion dollars in direct healthcare costs and more than 80,000 deaths within five years from heart damage.

Orion BioScience is a preclinical stage biotechnology company focused on developing innovative therapies to intercept disease and prevent development of symptoms in autoimmune conditions such as type-1 diabetes and neuromyelitis optica.

Viewpoint Molecular Targeting, Inc. develops radiopharmaceuticals for cancer therapy and diagnostic agents.

PVX is a broad spectrum antiviral therapeutics that could have profound implications on animal health, and subsequently on human health.